三力制药 (603439)
Guizhou Sanli Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameGuizhou Sanli Pharmaceutical Co., Ltd.
Listing Date2020-04-28
Issue Price7.35RMB
Registered Capital40893.021610k RMB
Legal RepresentativeZhang Hai
Registered AddressXiayun Industrial Park, Pingba District, Anshun City, Guizhou Province
IndustryTraditional Chinese Medicine II
Main BusinessResearch, development, production, and sales of pharmaceuticals.
Company ProfileGuizhou Sanli Pharmaceutical Co., Ltd. was founded in 1995. It is a modern Chinese medicine pharmaceutical enterprise integrating research, development, production, and marketing. It is a national high-tech enterprise, a designated manufacturer of national ethnic-specific commodities, and ranks among the top 100 private enterprises in Guizhou. It is annually recognized as an advanced taxpayer in Guizhou Province, having cumulatively created over 4 billion yuan in industrial output value, paid over 500 million yuan in taxes, and provided over 5,000 jobs for society. Sanli's headquarters is located in the Xiayun Industrial Park, Gui'an New District, Guizhou Province, a national high-tech industrial base. The first-phase project covers an area of 51,758.32 square meters with a total investment of 150 million yuan, capable of achieving an annual output value of no less than 2 billion yuan. It commenced production in November 2015 after passing the 2010 version GMP (Good Manufacturing Practice for Pharmaceutical Products) certification.
Stock Details
1. Key Indicators
- Total Shares(W): 40980.22
- Circulating A-Shares(W): 40384.02
- Earnings Per Share(RMB): 0.20
- Net Assets Per Share(RMB): 3.61
- Operating Revenue(W RMB): 103849.84
- Total Profit(W RMB): 9265.34
- **Net Profit Attributable to Parent(W RMB) **: 8078.70
- Net Profit Growth Rate(%): -58.39
- Weighted Return on Equity(%): 5.37
- Operating Cash Flow Per Share(RMB): 0.12
- Undistributed Profit Per Share(RMB): 2.15
- Capital Reserve Per Share(RMB): 0.39
2. Main Business
The main business covers:
- Research, development, production, and sales of pharmaceuticals.
3. Company Basic Information
- Company Name: Guizhou Sanli Pharmaceutical Co., Ltd.
- Listing Date: 2020-04-28
- Industry: Pharmaceutical Manufacturing
- Address: Xiayun Industrial Park, Pingba District, Anshun City, Guizhou Province
- Website: https://www.gz-sanli.com
- Company Profile: The company was established through the overall change of Sanli Co., Ltd. into a joint stock company. On January 5, 2015, Sanli Co., Ltd. passed a resolution at the shareholders' meeting to convert the audited net assets of 108.9159 million RMB as of December 31, 2014, into 50.15 million shares, thus transforming the company into a joint stock company. On January 30, 2015, the company completed its industrial and commercial registration with the Guizhou Provincial Administration for Industry and Commerce and obtained a business license with the registration number 520000000029334.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hainan Yuexin Pharmaceutical Investment Partnership (General Partnership) | Corporate Entity | 2019.01 | 5.00 |
| 2 | Shanghai Guosheng Capital Management Co., Ltd. - Shanghai Guosheng Haitong Private Equity Investment Fund Partnership (Limited Partnership) for High-Quality Development of Private Enterprises | Asset Management Plan | 777.57 | 1.93 |
| 3 | Guizhou Sanli Pharmaceutical Co., Ltd. Special Securities Account for Repurchase | Corporate Entity | 419.02 | 1.04 |
5. Concept Sectors
- New Retail
- Infant and Child Concept
- Smart Healthcare
- Innovative Drugs
- Specialized, Refined, Unique, and New (SRUN) Enterprises
- CSI Repurchase Index
- SSE 580 Index
Remarks
- Data update date: 2025-10-27
- Data source: Public market information